Synonyms: 5-[(5Z)-(5-Fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-2,4-dimethyl-N-[2-(pyrrolidin-1-yl)ethyl]-1H-pyrrole-3-carboxamide; PHA-291639; SU-11654; SU11654
Molecular Formula: C22H25FN4O2
Molecular Weight: 396.46
Linear Structural Formula: C22H25FN4O2
Purity: >=98% (HPLC)
Storage: room temp
Biochem Physiol Actions: Toceranib (SU11654) is a protein tyrosine kinase inhibitor that selectively targets stem cell factor receptor c-kit, including all forms of mutant Kit, as well as PDGFR and VEGFR. Toceranib exhibited Ki values of 5 nM for PDGFR and 6 nM for VEGFR. Toceranib phosphate is approved for use in mast cell cancer in dogs.
Legal Information: Sold for research purposes under agreement from Pfizer Inc.